CIRT Plus Durvalumab/ Tremelimumab Is Safe in Advanced HCC With Macrovascular Invasion.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 52
- By:
- Publication type:
- Article
Works matching IS 23745347 AND DT 2024 AND VI 25 AND IP 12
Results: 13
1
2
RPS-Optimized Checkpoint Inhibition Bolsters pCR Rates in Patients With Select Rare Breast Cancers.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 56
- By:
- Publication type:
- Article
3
Olomorasib Plus Pembrolizumab Generates Antitumor Activity in KRAS G12C+ NSCLC.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 50
- By:
- Publication type:
- Article
4
McKesson's Patient-Reported Outcomes Measure Will Track Improvements in Health-Related Social Needs.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 40
- By:
- Publication type:
- Article
5
Medicare Drug Price Negotiations Will Have Domino Effect for Community Oncology Practices.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 42
- By:
- Publication type:
- Article
6
TROP2 Offers Attractive Therapeutic Target in Breast Cancer and Other Solid Tumors.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 31
- By:
- Publication type:
- Article
7
ELEMENT-MDS May Broaden Luspatercept's Scope Into Non--Transfusion-Dependent Lower-Risk MDS.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 34
- By:
- Publication type:
- Article
8
CHEMOIMMUNOTHERAPY Is at the Forefront of the Perioperative NSCLC Paradigm.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 24
- By:
- Publication type:
- Article
9
Treatment Personalization Is Poised to Define New Era of mCRC Therapy.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 16
- By:
- Publication type:
- Article
10
Dostarlimab Plus Chemotherapy Opens Doors Across Endometrial Cancer Subtypes.
- Published in:
- 2024
- By:
- Publication type:
- Interview
11
Drug Spotlight.
- Published in:
- 2024
- Publication type:
- Chart/Diagram/Graph
12
Keeping You Abreast of All the Latest Conference Updates.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 4
- By:
- Publication type:
- Article
13
Molecularly Targeted Therapeutics Are Precisely Aimed.
- Published in:
- OncologyLive, 2024, v. 25, n. 12, p. 6
- By:
- Publication type:
- Article